Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
Arthur Johannes Anthonius Theodorus BraatDik J KwekkeboomBoen L R KamJaap J M TeunissenWouter W de HerderKoen M A DreijerinkRob van RooijGerard C KrijgerHugo W A M de JongMaurice A A J van den BoschMarnix G E H LamPublished in: BMC gastroenterology (2018)
Clinicaltrials.gov NCT02067988 , 13 February 2014. Protocol version: 6, 30 november 2016.